Welcome to LookChem.com Sign In|Join Free
  • or
HANGZHOU YUNUO CHEMICAL CO.,LTDARIPIPRAZOLE 129722-12-9//file1.lookchem.com/cas/reactions/2021/05/26/7951706.png
qq

You May Like:

Communicate with Supplier:

Ms. gong
Ms. gong: What can I do for you?

ARIPIPRAZOLE 129722-12-9 CAS NO.129722-12-9

Min.Order Quantity:
1 Kilogram
Purity:
99%
Port:
Shanghai, Ningbo, Tianjin, etc
Payment Terms:
L/C,T/T,

Add to Inquiry Cart

Product Details

Keywords

  • ARIPIPRAZOLE supplier in China
  • ARIPIPRAZOLE 99%
  • 129722-12-9 OPC 14597

Quick Details

  • ProName: ARIPIPRAZOLE 129722-12-9
  • CasNo: 129722-12-9
  • Molecular Formula: C23H27Cl2N3O2
  • Appearance: white crystalline powder
  • Application: It is an important raw material and me...
  • DeliveryTime: 15 days after order confirmed
  • PackAge: 1kg/bag, 1kg/drum or 25kg/drum or as p...
  • Port: Shanghai, Ningbo, Tianjin, etc
  • ProductionCapacity: 10 Kilogram/Month
  • Purity: 99%
  • Storage: Sealed in a cool ,dry and microtherm ...
  • Transportation: By express, air transportation or by s...
  • LimitNum: 1 Kilogram

Superiority

superior quality, moderate price & quick delivery.

Details

hangzhou yunuo chemical co., ltd. is located in hangzhou city, china. we are specialized in fine chemicals and medical intermediate, organic compounds, rubber chemicals etc. we have the advanced technology strength, owning delicate instruments and strong development team.

our value:
1. customer satisfaction is our priority and guarantee for the future,we are your faithful partner.
2. we co-develop products and projects with our partners.
3. we are passionate about the success of our projects, bound in an alliance of mutual benefit.

aripiprazole, sold under the brand name abilify among others, is an atypical antipsychotic. it is recommended and primarily used in the treatment of schizophrenia andbipolar disorder. other uses include as an add-on treatment in major depressive disorder, tic disorders, and irritability associated with autism. according to a cochrane review, evidence for the oral form in schizophrenia is not sufficient to determine effects on general functioning. additionally, because many people dropped out of the medication trials before they were completed, the overall strength of the conclusions is low.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)